These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 10582690

  • 1. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.
    Yang G, Truong LD, Wheeler TM, Thompson TC.
    Cancer Res; 1999 Nov 15; 59(22):5719-23. PubMed ID: 10582690
    [Abstract] [Full Text] [Related]

  • 2. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.
    Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229
    [Abstract] [Full Text] [Related]

  • 3. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression.
    Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC.
    Cancer; 2005 Mar 15; 103(6):1186-94. PubMed ID: 15712208
    [Abstract] [Full Text] [Related]

  • 4. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L, Jones TD, Lin H, Eble JN, Zeng G, Carr MD, Koch MO.
    J Urol; 2005 Dec 15; 174(6):2181-5. PubMed ID: 16280760
    [Abstract] [Full Text] [Related]

  • 5. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence.
    Karam JA, Lotan Y, Roehrborn CG, Ashfaq R, Karakiewicz PI, Shariat SF.
    Prostate; 2007 May 01; 67(6):614-22. PubMed ID: 17299799
    [Abstract] [Full Text] [Related]

  • 6. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD, Koch MO, Lin H, Cheng L.
    BJU Int; 2005 Dec 01; 96(9):1253-7. PubMed ID: 16287440
    [Abstract] [Full Text] [Related]

  • 7. Gleason score 7 prostate cancer on needle biopsy: is the prognostic difference in Gleason scores 4 + 3 and 3 + 4 independent of the number of involved cores?
    Makarov DV, Sanderson H, Partin AW, Epstein JI.
    J Urol; 2002 Jun 01; 167(6):2440-2. PubMed ID: 11992053
    [Abstract] [Full Text] [Related]

  • 8. Levels of expression of p27KIP1 protein in human prostate and prostate cancer: an immunohistochemical analysis.
    Erdamar S, Yang G, Harper JW, Lu X, Kattan MW, Thompson TC, Wheeler TM.
    Mod Pathol; 1999 Aug 01; 12(8):751-5. PubMed ID: 10463475
    [Abstract] [Full Text] [Related]

  • 9. Elevated expression of caveolin is associated with prostate and breast cancer.
    Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, Nasu Y, Bangma CH, Kattan MW, Scardino PT, Thompson TC.
    Clin Cancer Res; 1998 Aug 01; 4(8):1873-80. PubMed ID: 9717814
    [Abstract] [Full Text] [Related]

  • 10. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
    Sebo TJ, Bock BJ, Cheville JC, Lohse C, Wollan P, Zincke H.
    J Urol; 2000 Jan 01; 163(1):174-8. PubMed ID: 10604340
    [Abstract] [Full Text] [Related]

  • 11. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
    Swindle P, Eastham JA, Ohori M, Kattan MW, Wheeler T, Maru N, Slawin K, Scardino PT.
    J Urol; 2005 Sep 01; 174(3):903-7. PubMed ID: 16093984
    [Abstract] [Full Text] [Related]

  • 12. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 13. p53 nuclear protein expression is an independent prognostic marker in clinically localized prostate cancer patients undergoing radical prostatectomy.
    Bauer JJ, Sesterhenn IA, Mostofi KF, McLeod DG, Srivastava S, Moul JW.
    Clin Cancer Res; 1995 Nov 01; 1(11):1295-300. PubMed ID: 9815924
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage.
    Kato K, Hida Y, Miyamoto M, Hashida H, Shinohara T, Itoh T, Okushiba S, Kondo S, Katoh H.
    Cancer; 2002 Feb 15; 94(4):929-33. PubMed ID: 11920460
    [Abstract] [Full Text] [Related]

  • 15. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
    Masterson TA, Pettus JA, Middleton RG, Stephenson RA.
    Urology; 2005 Jul 15; 66(1):152-5. PubMed ID: 15992904
    [Abstract] [Full Text] [Related]

  • 16. Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
    Blute ML, Bergstralh EJ, Iocca A, Scherer B, Zincke H.
    J Urol; 2001 Jan 15; 165(1):119-25. PubMed ID: 11125379
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of syndecan-1 expression in patients treated with radical prostatectomy.
    Shariat SF, Svatek RS, Kabbani W, Walz J, Lotan Y, Karakiewicz PI, Roehrborn CG.
    BJU Int; 2008 Jan 15; 101(2):232-7. PubMed ID: 17868422
    [Abstract] [Full Text] [Related]

  • 18. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M, Stamey TA, McNeal JE, Yemoto CM.
    J Urol; 2000 Nov 15; 164(5):1596-600. PubMed ID: 11025712
    [Abstract] [Full Text] [Related]

  • 19. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA, Quast BJ, Wilson MJ, Fernandes ET, Reddy PK, Ewing SL, Gleason DF.
    Cancer; 2002 Jun 15; 94(12):3141-9. PubMed ID: 12115346
    [Abstract] [Full Text] [Related]

  • 20. Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort.
    Tahir SA, Frolov A, Hayes TG, Mims MP, Miles BJ, Lerner SP, Wheeler TM, Ayala G, Thompson TC, Kadmon D.
    Clin Cancer Res; 2006 Aug 15; 12(16):4872-5. PubMed ID: 16914574
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.